Development of Multiplex qPCR Platform Technology for Gene Therapy Product Potency Assessment

11:45 am - Thursday 3rd December 2026

  • Transition approaches of a dual-target AAV gene therapy potency assay from two separate reactions to a single multiplex PCR
  • Channels independence validation and establishing proper controls
  • Analytical performance qualification

Speakers:

Senior Scientist
Sanofi